We hypothesized that attenuation of maternal obesity and serum leptin in pregnant BPH/5 mice will improve fetoplacental development by decreasing hypoxia markers and leptin expression at the maternal-fetal interface. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.